Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-09-20

Clinical Trial Update: The Efficacy and Safety of HYDROXYUREA in Management of Beta Thalassemia Patients in Karachi Pakistan [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the efficacy and safety of hydroxyurea in managing beta-thalassemia in Karachi, Pakistan.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HYDROXYUREA (Hydroxyurea)

Snippet

Sponsor: Dr.Saqib Hussain Ansari | Conditions: Thalassemia, Beta | Phase 2 | Status: UNKNOWN